About Hydronovo, Inc
Hydronovo is a biotechnology company focused on developing regenerative therapies for xerostomia, or dry mouth, through stem cell reactivation. Their lead product, Ceviginate (CVGN8), is designed to restore salivary gland function and provide long-term relief.
Regenerative therapy development for xerostomiaStem cell reactivation using patented formulationsNerve-mimicking delivery methods for tissue regenerationResearch in salivary gland and nerve-organ interactionsTissue engineering and regenerative medicine technologies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to Hydronovo, Inc right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.